Oleuropein in Olive and its Pharmacological Effects by Omar, Syed Haris
Sci  Pharm   www.scipharm.at 
Review  Open Access 
Oleuropein in Olive and its  
Pharmacological Effects 
Syed Haris OMAR 
College of Pharmacy, Qassim University, P.O. Box-31922, Buraidah-51418, Saudi Arabia. 
E-mail: shamr@qu.edu.sa or syedharisomar@gmail.com  
Sci Pharm. 2010; 78: 133–154        doi:10.3797/scipharm.0912-18 
Published:   April 23
rd  2010     Received:    December  20
th 2009 
Accepted:   April 23
rd 2010 
This article is available from: http://dx.doi.org/10.3797/scipharm.0912-18 
© Omar; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction 
in any medium, provided the original work is properly cited. 
Abstract 
Olive from Olea europaea is native to the Mediterranean region and, both the oil 
and the fruit are some of the main components of the Mediterranean diet. The 
main active constituents of olive oil include oleic acid, phenolic constituents, and 
squalene. The main phenolic compounds, hydroxytyrosol and oleuropein, give 
extra-virgin olive oil its bitter, pungent taste. The present review focuses on 
recent works that have analyzed the relationship between the major phenolic 
compound oleuropein and its pharmacological activities including antioxidant, 
anti-inflammatory, anti-atherogenic, anti-cancer activities, antimicrobial activity, 
antiviral activity, hypolipidemic and hypoglycemic effect.  
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1. Introduction 
Several species within the olive family, botanically known as Olea europaea, provide 
commercial products such as food, lumber, cosmetics and medicine. Olive oil is a 
component of the Mediterranean diet, containing variable amounts of triacylglycerols and 
small quantities of free fatty acids, glycerol, pigments, aroma compounds, sterols, 
tocopherols, phenols, unidentified resinous components and others [1]. The pharmaco-
logical properties of olive oil, the olive fruit and its leaves have been recognized as 
important components of medicine and a healthy diet because of their phenolic content [2]. 
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2. Occurrence 
Phenolic compounds are found in all parts of the olive plant, but their nature and 
concentration varies greatly between the various tissues (Fig. 1). In Olea europaea, 
oleuropein, demethyl-oleuropein, ligstroside, and oleoside represent the predominant 
phenolic oleosides [3], whereas verbascoside [4] is the main hydroxycinnamic derivative of 
the olive fruit [5]. Oleuropein is generally the most prominent phenolic compound in olive 
cultivars and can reach concentrations of up to 140 mg g
−1 
on a dry matter basis in young 
olives [6] and 60–90 mg g
−1 
of dry matter in the leaves [7].  
Various methods have been developed to analyze the qualitative and quantitative 
occurrence of phenolic and secoiridoid compounds: the simple techniques include Thin 
Layer Chromatography (TLC) [8], reversed phase High Performance Liquid 
Chromatography (HPLC) [9, 10], Gas Chromatography-Mass Spectrometry (GC-MS) [11] 
and Capillary Electrophoresis (CE) [12]; and the sophisticated methods involve Full 
Automatic Modeling System (FAMS) or Tetramethylsilane NMR [13], Electrospray 
Ionization Tandem Mass Spectrometry (ESI-MS/MS) and High-Resolution Measurements 
(HRMS) [14] LC/SPE/NMR, 2D-NMR, MALDI-TQF-MS [15–18]. In the fruits, phenyl acids, 
flavonoids and secoiridoids have been reported, with phenolic compounds representing 1–
3% (w/v) of the olive [19]. In the leaves, oleuropein makes up 19% (w/w) and flavonoids 
make up 1.8% (w/w), of which 0.8% is luteolin 7-glucoside [7]. 
Oleuropein not only occurs in the Olea  genus, but also occurs in many other genera 
belonging to the Oleaceae family and has been previously described in Fraxinus excelsior,   Oleuropein in Olive and its Pharmacological Effects  137 
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F. angustifolia, F. chinensis, Syringa josikaea, S. vulgaris, Philyrea latifolia, Ligustrum 
ovalifolium, L. vulgare, and many others [3]. 
 
3. Chemistry, biosynthesis and fate of oleuropein 
3.1. Chemistry 
Oleuropein belongs to the secoiridoids, which are abundant in Oleaceae, Gentianaceae, 
Cornaleae, as well as many other plants. Iridoids and secoiridoids are compounds that are 
usually glycosidically bound and are produced from the secondary metabolism of terpenes 
as precursors of various indole alkaloids. The secoiridoids in Oleaceae are usually derived 
from the oleoside type of glucosides (oleosides), which are characterized by an exocyclic 
8,9-olefinic functionality, a combination of elenolic acid and a glucosidic residue. 
Oleuropein is an ester of 2-(3,4-dihydroxyphenyl)ethanol (hydroxytyrosol) and has the 
oleosidic skeleton that is common to the secoiridoid glucosides of Oleaceae [3], mainly in 
its aglycone form, which makes the sugar moiety insoluble in oil (Fig. 2). 
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Fig. 2.   Structures of oleuropein and oleuropein aglycone 
3.2. Biosynthesis of oleuropein 
The biosynthesis of oleuropein in Oleaceae proceeds via a branching in the mevalonic 
acid pathway from the secondary metabolism, resulting in the formation of oleosides [20]. 
From these compounds, secoiridoids are derived [21]. The biosynthesis of oleosides is 
similar to that of secologanin-derived secoiridoids in Gentianales and Cornales. In these 
compounds, the carbon skeleton is derived from mevalonic acid. Geraniol, 
10-hydroxygeranoil as well as 10-hydroxynerol and iridoidal are known precursors of 
loganin. Later, deoxyloganic acid, 7-epiloganic acid and loganic acid are incorporated into 
ligustroside, a direct precursor of oleuropein, via a 7-ketologanic acid intermediate. The 
sequences of the steps between deoxyloganic acid and 7-ketologanin may differ between 
plant species and times of the year [22]. In O. europaea, both possible epoxides of 
secologanin and secoxyloganin can be precursors for oleuropein [21]. A plausible 
biosynthetic route from deoxyloganic acid, 7-epiloganic acid, 7-ketologanic acid, 
8-epikingisidic acid, oleoside 11-methyl ester, 7-β-1-D-glucopyranosyl 11-methyl oleoside 
and ligustroside to oleuropein was proposed by Damtoft et al. [21] for Oleaceae (Fig. 3). 
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3.3. Fate of oleuropein 
In the development of the olive fruit, three phases are usually distinguished: a growth 
phase, during which accumulation of oleuropein occurs; a green maturation phase that 
coincides with a reduction in the levels of chlorophyll and oleuropein; and a black 
maturation phase that is characterized by the appearance of anthocyanins and during 
which the oleuropein levels continue to fall [23]. Therefore, oleuropein is very abundant in 
the early stages: in young fruits, it can reach 14% of dry matter. Although lower, its level is 
still very important at harvest for green picked cultivars [24]. In black cultivars, its level 
declines rapidly during maturation [25]; in some varieties (Oeuropaea var leccino), it can 
even fall to zero when the fruits are completely black [26]. Elenolic acid glucoside and 
demethyloleuropein, glucosylated derivatives of oleuropein, appear at the beginning of 
green maturation as the oleuropein levels decline. Then, they accumulate, reaching their 
maximum during black maturation, until demethyloleuropein becomes the major 
constituent of black olives [26]. It is possible that these two compounds are formed from 
oleuropein by the action of esterases because esterase activity increases considerably 
during the first phase of maturation and reaches a maximum during black maturation [23]. 
The fruit of Olea europaea appears to accumulate only glucosylated derivatives of 
oleuropein. In contrast, dihydroxytyrosol and non-glucosylated secoiridoids derived from 
oleuropein have been found in the leaves [23,  27]. The decline in oleuropein also 
coincides with the decline in other quantitatively less important oleosides such as 
ligustroside and the increase in other phenolic compounds such as certain flavonoids and 
verbascoside [23]. In small, young olives, verbascoside is present only in traces, while 
ligustroside and cornoside are relatively abundant. When green olives reach normal size, 
the ligustroside disappears, and cornoside follows the same trend as the other 
compounds, easily transforming into halleridone [26]. 
Considerable differences in the content of tyrosol, hydroxytyrosol and tyrosol glucoside 
have also been found in the fruits during growth and ripening of the drupe [28, 29]; the 
increase in their levels consistently correlates with hydrolysis of the components with 
higher molecular weights [30]. The elenolic acid glucoside and hydroxytyrosol contents 
can be considered indicators for the maturation of olives [31]. Because of its interaction 
with a diphenol oxidase (PPO; EC 1.10.3.2), oleuropein is also involved in the browning 
that occurs in green table olives either after impact and wounding during harvesting or 
during subsequent processing treatments. Initially, this PPO is associated with the 
chloroplast membranes but becomes increasingly soluble during maturation. 
Therefore, the degree of browning varies considerably depending on the physiological 
stage of the fruit. Browning was found to correlate with the oleuropein content and not with 
PPO activity, indicating that endogenous substrates are the main limiting factor [32]. 
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4. Bioavailability of oleuropein 
Phenolic compounds from virgin olive oil have been demonstrated to be highly 
bioavailable. Vissers et al. found that absorption of administered ligistroside-aglycone, 
hydroxytyrosol, tyrosol and oleuropein-aglycone was 55–60% in human subjects [33]. 
They also suggested that an important step in the metabolism of olive oil phenolics 
oleuropein-glycoside to oleuropein ad ligistroside-aglycones is their formation into 
hydroxytyrosol or tyrosol [33]. This hypothesis was supported by their finding that 15% of 
an oleuropein-glycoside supplement administered to healthy human subjects was excreted 
in urine as hydroxytyrosol and tyrosol [33]. Another two studies showed that oleuropein is 
rapidly absorbed after oral administration with a maximum plasma concentration occurring 
2  h after administration. Hydroxytyrosol was its most important metabolite. Both 
compounds are rapidly distributed and excreted in urine mainly as glucoronides or in very 
low concentrations as free forms [34, 35]. Furthermore, the mechanism of absorption of 
olive oil phenolics remains unclear. 
5. Oleuropein and Health 
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Fig. 4.   Pharmacological effects of oleuropein 
Oleuropein has several pharmacological properties (Fig. 4), including antioxidant [2], anti-
inflammatory [36], anti-atherogenic [37], anti-cancer [38], antimicrobial [39], and antiviral 
[40], and for these reasons, it is commercially available as food supplement in 
Mediterranean countries. In addition, oleuropein has been shown to be cardioprotective 
against acute adriamycin cardiotoxicity [41] and has been shown to exhibit anti-ischemic 
and hypolipidemic activities [42]. 
5.1. Antioxidant activity 
Oleuropein potently and dose-dependently inhibits copper sulphate-induced oxidation of 
low-density lipoproteins (LDL) [43, 44]. According to De la Puerta et al. [45], oleuropein   Oleuropein in Olive and its Pharmacological Effects  141 
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has both the ability to scavenge nitric oxide and to cause an increase in the inducible nitric 
oxide synthase (iNOS) expression in the cell. A scavenging effect of oleuropein was 
demonstrated with respect to hypochlorous acid (HOCl) [43]. HOCl is an oxidative 
substance produced in vivo by neutrophil myeloperoxidase at the site of inflammation and 
can cause damage to proteins including enzymes. 
Coni et al. [46] conducted a study with laboratory rabbits fed special diets that contained 
olive oil and oleuropein. The results indicate that the addition of oleuropein increases the 
ability of LDL to resist oxidation and at the same time reduces the plasma levels of total, 
free, and esterified cholesterol. 
Additionally, the potential protective effects of oleuropein have been investigated in 
isolated rat hearts by Manna et al. [47]. The organs were subjected to 30 min of no-flow 
global ischemia and then reperfused. At different intervals, the coronary heart effluent was 
collected and assayed for creatine kinase activity and reduced and oxidized glutathione. 
The extent of lipid peroxidation was evaluated by measuring the concentration of 
thiobarbituric acid-reactive substance in the muscle. According to the authors, the findings 
of the study strengthen the hypothesis that the health benefits of olive oil are related to the 
oleuropein derivatives that are present in olive oil. De la Puerta et al. [48] determined the 
anti-eicosanoid and antioxidant effects in leukocytes of the principal phenolic compounds 
(oleuropein, tyrosol, hydroxytyrosol and caffeic acid) from the polar fraction of olive oil. 
Moreover, Visioli et al. [49] demonstrated that the administration of catecholic phenolic 
from olive oil (oleuropein) dose-dependently decreases the urinary excretion of 8-iso- 
PGF2α, indicating lower in vivo lipid peroxidation in supplemented volunteers.  
5.2. Anti-inflammatory effect  
Visioli et al. [36] showed that oleuropein increases nitric oxide (NO) production in 
macrophages challenged with lipopolysaccharide through induction of the inducible form of 
the enzyme nitric oxide synthase, thus increasing the functional activity of these 
immunocompetent cells. It is well known that oleuropein elicits anti-inflammatory effects by 
inhibiting lypoxygenase activity and the production of leukotriene B4 [48].  
5.3. Anti-atherogenic effect 
Visioli and Galli reported that Oleuropein shows anti-atherogenic activity [50]. In 2003, 
Carluccio MA et al. [51] reported that oleuropein reduces monocytoid cell adhesion to 
stimulated endothelium as well as vascular cell adhesion molecule-1 (VCAM-1) mRNA and 
protein. Reflow in ischemic hearts was accompanied by a prompt release of oxidized 
glutathione; in ischemic hearts pretreated with oleuropein, this release was significantly 
reduced and was accompanied by prevention of membrane lipid peroxidation, which is 
considered a key factor in the pathogenesis of atherosclerosis [47]. 
5.4. Anti-cancer effect 
A plethora of minor constituents in olive oil have been identified as effective agents in 
mitigating the initiation, promotion and progression of multistage carcinogenesis.  
Hamdi and Castellon showed that oleuropein inhibits growth of LN-18 cells, a poorly 
differentiated glioblastoma cell line; TF-1a, a erythroleukemia; and tumor cell lines derived 
from advanced-grade human tumors (786-O, renal cell adenocarcinoma; T-47D, infiltrating 142  S. H. Omar:   
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ductal carcinoma of the breast pleural effusion; RPMI-7951, malignant melanoma of the 
skin-lymph node metastasis; and LoVo, colorectal adenocarcinoma cells) in Swiss albino 
mice with soft tissue sarcoma [52]. 
Menendez et al. [53] showed that oleuropein aglycone is the most potent phenolic 
compound in decreasing breast cancer cell viability. HER2 oncogene-amplified SKBR3 
cells were ~5-times more sensitive to oleuropein aglycone than HER2-negative MCF-7 
cells. 
Subsequently, Menendez et al. [54] showed that the secoiridoids deacetoxy oleuropein 
aglycone, ligstroside aglycone, and oleuropein aglycone, induce strong tumoricidal effects 
within a micromolar range by selectively triggering high levels of apoptotic cell death in 
HER2-overexpressing breast carcinomas. These compounds markedly depleted HER2 
protein and reduced HER2 tyrosine autophosphorylation in a dose- and time-dependent 
manner [54]. 
Recently, Han et al. [55] reported that 200 lg/mL of oleuropein remarkably reduces the 
viability of MCF-7 cells and decreases the number of MCF-7 cells by inhibiting the rate of 
cell proliferation and inducing cell apoptosis. Additionally, oleuropein exhibited a 
statistically significant block of G1 to S phase transition, which was manifested by the 
increase in the number of cells in the G0/G1 phase [55]. 
Goulas et al. [56] demonstrated the antiproliferative activity of crude extracts and 
phytochemicals (the dominant compound of the extracts is oleuropein) against cell lines at 
low micromolar concentrations. These extracts inhibit cell proliferation of human breast 
adenocarcinoma (MCF-7), human urinary bladder carcinoma (T-24) and bovine brain 
capillary endothelial (BBCE).  
5.5. Antimicrobial effect 
Oleuropein has been shown to have strong antimicrobial activity against both Gram-
negative and Gram-positive bacteria [57–59] as well as mycoplasma [60]. Phenolic 
structures similar to oleuropein seem to produce its antibacterial effect by damaging the 
bacterial membrane and/or disrupting cell peptidoglycans. Different authors have used 
biophysical assays to study the interaction between oleuropein and membrane lipids [61]; 
however, the exact mechanism of the antimicrobial activity of oleuropein is still not 
completely established, although some authors have proposed that it is due to the 
presence of the ortho-diphenolic system (catechol) [57]. In 2001, Saija and Uccella [62] 
proposed that the glycoside group modifies the ability to penetrate the cell membrane and 
get to the target site. Effective interference with the production procedures of certain amino 
acids necessary for the growth of specific microorganisms has also been suggested. 
Another mechanism proposed is the direct stimulation of phagocytosis as a response of 
the immune system to microbes of all types. 
Oleuropein and hydrolysis products are able to inhibit the development and production of 
enterotoxin B by Staphylococcus aureus, the development of Salmonella enteritidis and 
the germination and consequent development of spores of Bacillus cereus [57–67]. 
Oleuropein and other phenolic compounds (p-hydroxybenzoic, vanillic and p-coumaric 
acids) completely inhibit the development of Klebsiella pneumoniae, Escherichia coli and 
B. cereus [58].   Oleuropein in Olive and its Pharmacological Effects  143 
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Recently, Sudjana et al. [68] showed the antimicrobial activity of commercial Olea 
europaea (olive) leaf extracts (abundantly oleuropein) against Campylobacter jejuni, 
Helicobacter pylori and methicillin-resistant Staphylococcus aureus (MRSA). The authors 
also demonstrated these extracts play a role in regulating the composition of the gastric 
flora by selectively reducing levels of H. pylori and C. jejuni. 
5.6. Antiviral effect 
In a U.S. patent, it has been claimed that oleuropein has potent antiviral activities against 
herpes mononucleosis, hepatitis virus, rotavirus, bovine rhinovirus, canine parvovirus, and 
feline leukemia virus [69]. Studies have also shown that oleuropein exhibits a significant 
antiviral activity against respiratory syncytial virus and para-influenza type 3 virus [70]. 
There is also one anecdotal report that olive leaf extracts augment the activity of the HIV-
RT inhibitor 3TC [71]. The olive leaf extracts were investigated for their antiviral activity 
against viral hemorrhagic septicemia virus (VHSV), a salmonid rhabdovirus, and against 
HIV-1 infection and replication [72]. Cell-to-cell transmission of HIV was inhibited in a 
dose-dependent manner with EC50s of 0.2 µg/ml, and HIV replication was inhibited in an in 
vitro experiment [73].  
One of the suspected targets for olive leaf extract (mainly oleuropein) action is HIV-1 gp41 
(surface glycoprotein subunit), which is responsible for HIV entry into normal cells. In order 
to establish HIV protein targets of olive leaf extract and its inhibitory action at the molecular 
level, Lee-Huang et al. [74] reported a joint theoretical and experimental effort has been 
carried out to help achieve this goal. 
5.7 Skin protectant 
Ancora et al. [75] have shown that the phenol components of olive oil have a direct 
antioxidant action on skin, especially oleuropein, which acts as a free radical scavenger at 
the skin level. Recently, Kimura and Sumiyoshi [76] suggested that the preventative 
effects of olive leaf extracts and oleuropein on chronic UVB-induced skin damage and 
carcinogenesis and tumor growth may be due to inhibition of the expression of VEGF, 
MMP-2, MMP-9, and MMP-13 through a reduction in COX-2 levels. 
5.8 Anti-aging 
Normal human fibroblasts undergo replicative senescence due to both genetic and 
environmental factors. The proteasome, a multicatalytic nonlysosomal protease, has 
impaired function during aging, while its increased expression delays senescence in 
human fibroblasts. Katsiki et al. [77] demonstrated that oleuropein enhances proteasome 
activities in vitro more effectively than other known chemical activators, possibly through 
conformational changes of the proteasome. Moreover, continuous treatment of early 
passage human embryonic fibroblasts with oleuropein decreases the intracellular levels of 
reactive oxygen species (ROS), reduces the amount of oxidized proteins through 
increased proteasome-mediated degradation rates and retains proteasome function during 
replicative senescence. Importantly, oleuropein-treated cultures exhibit a delay in the 
appearance of senescence morphology, and their life span is extended by approximately 
15% [77]. 
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Fig. 5.   Diagrammatic representation of the neuroprotective role of oleuropein 
5.9 Neuroprotective activity 
According to the free radical theory, aging is the result of oxidative injury, mainly to 
mitochondria, over the lifetime of an individual. Some of the oxidative damage cannot be 
entirely counteracted, which leads to cellular dysfunction. Mitochondrial membranes are 
very sensitive to free radical attack because of the presence of a double bond carbon-
carbon in the lipid tails of its phospholipids, which leads to the production of cognitive and 
neurodegenerative disease. In vitro [78] and epidemiological [79] studies have pointed out 
the positive impact of natural extracted polyphenols on the incidence of age-related 
disorders, such as dementia. One study [80] has reported that oleuropein decreases or 
even prevents Aβ aggregation, which is inherent to Alzheimer’s disease (AD). The 
potential effect of oleuropein on brain function in AD is analogous to atherosclerosis 
because they both are age-dependent diseases in which abnormal accumulation of a 
normal metabolite (cholesterol and Aβ, respectively) precedes clinical symptoms and leads 
to disease [81,82]. The link between heart disease, hypercholesterolemia, and AD [83] is 
due to similar mechanisms of pathogenesis of these disorders. The circumstantial 
evidence that cholesterol-related interventions can alter Aβ deposition [84, 85] suggests 
that oleuropein might be promising in the management of AD. Furthermore, the 
importance of inflammatory processes in the clinical manifestation of AD [86,  87],   Oleuropein in Olive and its Pharmacological Effects  145 
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combined with the epidemiological evidence of a protective effect of anti-inflammatory 
agents [88] against AD, suggest that a polyphenolic natural extract, such as oleuropein, 
could prove effective against age-dependent disease. The diagrammatic representation of 
the neuroprotective role of oleuropein is shown in Figure 5. 
5.10 Other activity 
Further pharmacological activity of oleuropein includes diverse healing properties due to 
its vasodilatory [89], anti-platelet aggregation [90], hypotensive [91,  92], anti-rheumatic 
[36], diuretic [91] and antipyretic [93] effects. Prevention of free radical formation by 
oleuropein occurs through its ability to chelate metal ions, such as Cu and Fe, which 
catalyze free radical generation reactions [94], and through its inhibitory effect on several 
inflammatory enzymes like lipoxygenases [48]. Previously, oleuropein was reported to 
have an anti-hyperglycemic effect in diabetic rats [95]. Oleuropein inhibits hyperglycemia 
and oxidative stress induced by diabetes, which suggests that administration of oleuropein 
is helpful in the prevention of diabetic complications associated with oxidative stress [96]. 
6. Conclusion 
Oleuropein, the main glycoside present in olives, and hydroxytyrosol, the principal 
degradation product of oleuropein present in olive oil, have both been linked to reduction 
of coronary heart disease and certain cancers. 
There are still numerous key issues that need to be answered, and these will require 
further research. Specifically, one question that remains unanswered is what the 
neuroprotective (Dementia, Parkinson’s, Alzheimer’s and Schizophrenia) roles of 
oleuropein are? 
Author’s Statement 
The author declares no conflict of interest. 
References 
[1]  Kiritsakis A.  
Olive oil- Second Edition, From the tree to the table. Food and Nutrition. 
Press, Inc., Trumbull, Connecticut, USA. 1998:006611. 
[2]  Visioli F, Poli A, Galli C.  
Antioxidant and other biological activities of phenols from olives and olive oil. 
Med Res Rev. 2002; 22: 65–75. 
doi:10.1002/med.1028 
[3]  Soler-Rivas C, Espin JC, Wichers HJ. 
Oleuropein and related compounds. 
J Sci Food Agric. 2000; 80: 1013–1023. 
doi:10.1002/(SICI)1097-0010(20000515)80:7<1013::AID-JSFA571>3.0.CO;2-C  
[4]  Ryan D, Robards K, Prenzler P, Jardine D, Herlt T, Antolovich M. 
Liquid chromatography with electrospray ionisation mass spectrometric detection of phenolic 
compounds from Olea europaea.  
J Chromatogr A. 1999; 855: 529–537. 
doi:10.1016/S0021-9673(99)00719-0 146  S. H. Omar:   
Sci Pharm. 2010; 78: 133–154. 
[5]  Servili M, Baldioli M, Selvaggini R, Macchioni A, Montedoro G. 
Phenolic compounds of olive fruit: one- and two-dimensional nuclear magnetic resonance 
characterization of Nuzhenide and its distribution in the constitutive parts of fruit.  
J Agric Food Chem. 1999; 47: 12–18. 
doi:10.1021/jf9806210 
[6]  Amiot MJ, Fleuriet A, Macheix JJ.  
Importance and evolution of phenolic compounds in olive during growth and maturation. 
J Agric Food Chem. 1986; 34: 823–826. 
doi:10.1021/jf00071a014 
[7] Le  Tutour  B,  Guedon  D. 
Antioxidant activities of Olea europaea leaves and related phenolic compounds.  
Phytochemistry. 1992; 31: 1173–1178. 
doi:10.1016/0031-9422(92)80255-D 
[8]  Capasso R, Evidente A, Scognamiglio F.  
A simple thin layer chromatographic method to detect the main polyphenols occurring in olive oil 
vegetation waters.  
Phytochem Anal. 1992; 3: 270–275. 
doi:10.1002/pca.2800030607 
[9]  Ficarra P, Ficarra R, de Pasquale A, Monforte MT, Calabro ML.  
HPLC analysis of oleuropein and some flavonoids in leaf and bud of Olea europaea L.  
Farmaco. 1991; 46: 803–815. 
PMid:1772565 
[10]  De Laurentis N, Crescenzo G, Lai OR, Milillo MA. 
Investigation on the extraction and concentration of oleuropein and flavonoids in Olea europaea L. 
based products. 
Pharm Pharmacol Lett. 1997; 7: 27–30. 
[11]  Campeol E, Flamini G, Chericoni S, Catalano S, Cremonini R.  
Volatile compounds from three cultivars of Olea europaea from Italy. 
J Agric Food Chem. 2001; 49: 5409–5411. 
doi:10.1021/jf010455n 
[12]  Bonoli M, Bendini A, Cerretani L, Lercker G, Toschi TG. 
Qualitative and semiquantitative analysis of phenolic compounds in extra virgin olive oils as a function 
of the ripening degree of olive fruits by different analytical techniques. 
J Agric Food Chem. 2004; 52: 7026–7032. 
doi:10.1021/jf048868m 
[13]  Baracco A, Bertin G, Gnocco E, Legorati M, Sedocco S, Catinella S, Favretto D, Traldi P.  
A comparison of the combination of fast-atom bombardment with tandem mass spectrometry and of 
gas chromatography with mass spectrometry in the analysis of a mixture of kaempferol, kaempferide, 
luteolin and oleuropein.  
Rapid Commun Mass Spectrom. 1995; 9: 427–436. 
doi:10.1002/rcm.1290090512 
[14]  Di Donna L, Mazzotti F, Salerno R, Tagarelli A, Taverna D, Sindona G. 
Characterization of new phenolic compounds from leaves of Olea europaea L. by high-resolution 
tandem mass spectrometry. 
Rapid Commun Mass Spectrom. 2007; 21: 3653–3657. 
doi:10.1002/rcm.3262 
[15]  Exarchou V, Godejohann M, van Beek TA, Gerothanassis IP, Vervoort J. 
LC-UV-solid-phase extraction-NMR-MS combined with a cryogenic flow probe and its application to 
the identification of compounds present in Greek oregano. 
Anal Chem. 2003; 75: 6288–6294. 
doi:10.1021/ac0347819   Oleuropein in Olive and its Pharmacological Effects  147 
Sci Pharm. 2010; 78: 133–154. 
[16]  Exarchou V, Troganis A, Gerothanassis IP, Tsimidou M, Boskou D. 
Identification and quantification of caffeic and rosmarinic acid in complex plant extracts by the use of 
variable-temperature two-dimensional nuclear magnetic resonance spectroscopy. 
J Agric Food Chem. 2001; 49: 2–8. 
doi:10.1021/jf990928e 
[17]  Tatsis EC, Boeren S, Exarchou V, Troganis AN, Vervoort J, Gerothanassis IP. 
Identification of the major constituents of Hypericum perforatum by LC/SPE/NMR and/or LC/MS. 
Phytochemistry. 2007; 68: 383–393. 
doi:10.1016/j.phytochem.2006.11.026 
[18] Anderson OM, Markham KR.  
Flavonoids: chemistry, biochemistry and applications.  
Florida: Taylor & Francis, 2006. 
[19]  Brenes M, Garcia P, DuranMC, Garrido A. 
Concentration of phenolic compounds change in storage brines of ripe olives.  
J Food Sci. 1993; 58: 347–350. 
doi:10.1111/j.1365-2621.1993.tb04272.x 
[20]  Damtoft S, Franzyk H, Jensen SR.  
Excelsioside, a secoiridoid glucoside from Fraxinus excelsior.  
Phytochemistry. 1992; 31: 4197–4201. 
 doi:10.1016/0031-9422(92)80442-H 
[21]  Damtoft S, Franzyk H, Jensen SR.  
Biosynthesis of secoiridoid glucosides in Oleaceae.  
Phytochemistry. 1993; 34: 1291–1299. 
doi:10.1016/0031-9422(91)80018-V 
[22]  Damtoft S, Franzyk H, Jensen SR.  
Biosynthesis of iridoids in Syringa and Fraxinus: carbocyclic iridoid precursors.  
Phytochemistry. 1995; 40: 785–792. 
doi:10.1016/0031-9422(95)00210-X 
[23]  Amiot MJ, Fleuriet A, Macheix JJ.  
Accumulation of oleuropein derivatives during olive maturation. 
Phytochemistry. 1989; 28: 67–70. 
doi:10.1016/0031-9422(89)85009-5 
[24]  Amiot MJ, Fleuriet A, Macheix JJ. 
Importance and evolution of phenolic compounds in olive during growth and maturation. 
J Agric Food Chem.1986; 34: 823–826. 
doi:10.1021/jf00071a014 
[25]  Limiroli R, Consonni R, Ottolina G, Marsilio V, Bianchi G, Zetta L.  
1H and 
13C NMR characterization of new oleuropein algycones.  
J Chem Soc Perkin Trans 1. 1995; 1519–1523. 
doi:10.1039/P19950001519 
[26]  Bianco A, Lo Scalzo R, Scarpati ML.  
Isolation of cornoside from Olea europaea and its transformation into halleridone.  
Phytochemistry. 1993; 32: 455–457. 
doi:10.1016/S0031-9422(00)95015-5 
[27]  Amiot MJ, Tacchini M, Fleuriet A, Macheix JJ.  
The technological debittering process of olives: characterization of fruits before and during alkaline 
treatment.  
Sci Aliments. 1990; 10: 619–632. 
[28]  Angerosa F, D'Alessandro N, Konstantinou P, Di Giacinto L.  
GC-MS evaluation of phenolic compounds in virgin olive oil.  
J Agric Food Chem. 1995; 43: 1802–1807. 
doi:10.1021/jf00055a010 148  S. H. Omar:   
Sci Pharm. 2010; 78: 133–154. 
[29]  Limiroli R, Consonni R, Ranalli A, Bianchi G, Zetta L. 
1H NMR study of phenolics in the vegetation water of three cultivars of Olea europaea: similarities and 
differences.  
J Agric Food Chem. 1996; 44: 2040–2048. 
doi:10.1021/jf9507349 
[30]  Climato A, Mattei A, Osti M.  
Variation of polyphenol composition with harvesting period.  
Acta Hort. 1990; 286: 453–456. 
[31]  Esti M, Cinquanta L, Notte EI, La Notte E.  
Phenolic compounds in different olive varieties.  
J Agric Food Chem. 1998; 46: 32–35. 
doi:10.1021/jf970391+ 
[32]  Goupy P, Fleuriet A, Amiot MJ, Macheix JJ.  
Enzymatic browning, oleuropein content, and diphenol oxidase activity in olive cultivars (Olea 
europaea L.). 
J Agric Food Chem. 1991; 39: 92–95. 
doi:10.1021/jf00001a017 
[33]  Vissers MN, Zock PL, Roodenburg AJC, Leenen R, Katan MB.  
Olive oil phenols are absorbed in humans.  
J Nutr. 2002; 132: 409–417. 
PMid:11880564 
[34]  Tan HW, Tuck KL, Stupans I, Hayball PJ.  
Simultaneous determination of oleuropein and hydroxytyrosol in rat plasma using liquid 
chromatography with fluorescence detection. 
J Chromatogr B. 2003; 785: 187–191. 
doi:10.1016/S1570-0232(02)00855-3 
[35]  Boccio P, DiDeo A, De Curtis A, Celli N, Iacoviello L, Rotilio D.  
Liquid chromatography-tandem mass spectrometry analysis of oleuropein and its metabolite 
hydroxytyrosol in rat plasma and urine after oral administration.  
J Chromatogr B. 2003; 785: 47–56. 
doi:10.1016/S1570-0232(02)00853-X 
[36]  Visioli F, Bellosta S, Galli C.  
Oleuropein, the bitter principles of olives, enhances nitric oxide production by mouse macrophages.  
Life Sci. 1998; 62: 541–546. 
doi:10.1016/S0024-3205(97)01150-8 
[37]  Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, Distante A, 
De Caterina R. 
Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties 
of mediterranean diet phytochemicals.  
Arterioscler Thromb Vasc Biol. 2003; 23: 622–629. 
doi:10.1161/01.ATV.0000062884.69432.A0 
[38]  Owen RW, Giacosa A, Hull WE, Haubner R, Würtele G, Spiegelhalder B, Bartsch H.  
Olive oil consumption and health: the possible role of antioxidants.  
Lancet Oncol. 2000; 1: 107–112. 
doi:10.1016/S1470-2045(00)00015-2 
[39]  Tripoli E, Giammanco M, Tabacchi G, Di Majo D, Giammanco S, La Guardia M.  
The phenolic composition of olive oil: structure, biological activity, and beneficial effects on human 
health.  
Nutr Res Rev. 2005; 18: 98–112. 
doi:10.1079/NRR200495   Oleuropein in Olive and its Pharmacological Effects  149 
Sci Pharm. 2010; 78: 133–154. 
[40]  Fredrickson WR, F and S Group, Inc.  
Method and Composition for Antiviral Therapy with Olive Leaves.  
U.S. Patent. 2000; 6: 117,884. 
[41]  Andreadou I, Sigala F, Iliodromitis EK, Papaefthimiou M, Sigalas C, Aligiannis N, Savvari P, 
Gorgoulis V, Papalabros E, Kremastinos DT.  
Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through 
suppression of oxidative and nitrosative stress.  
J Mol Cell Cardiol. 2007; 42: 549–558. 
doi:10.1016/j.yjmcc.2006.11.016 
[42]  Andreadou I, Iliodromitis EK, Mikros E, Constantinou M, Agalias A, Magiatis P, Skaltsounis AL, 
Kamber E, Tsantili-Kakoulidou A, Kremastinos DT.  
The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in 
anesthetized rabbits.  
J Nutr. 2006; 136: 2213–2219. 
PMid:16857843 
[43]  Visioli F, Galli C, Galli G, Caruso D.  
Biological activities and metabolic fate of olive oil phenols.  
Eur J Lipid Sci Technol. 2002; 104: 677–684. 
doi:10.1002/1438-9312(200210)104:9/10<677::AID-EJLT677>3.0.CO;2-M 
[44]  Visioli F, Bogani P, Galli C.  
Healthful properties of olive oil minor components, in Olive Oil, Chemistry and Technology. 
Boskou D (Ed.). 
AOCS Press, Champaign, IL: 2006: 173–190. 
[45]  De la Puerta R, Dominguez MEM, Ruiz-Guttierrez V, Flavill JA, Hoult JRS.  
Effects of olive oil phenolics on scavenging of reactive nitrogen species and upon nitrergic 
neurotransmission.  
Life Sci. 2001; 69: 1213–1222. 
doi:10.1016/S0024-3205(01)01218-8 
[46]  Coni E, Benedetto R, Pasquale M, Masella R, Modesti D, Mattei R, Carline EA.  
Protective effect of oleuropein, an olive oil biophenol, on low density lipoprotein oxidizability in rabbits.  
Lipids. 2000; 35: 45–54. 
doi:10.1007/s11745-000-0493-2 
[47]  Manna C, Migliardi V, Golino P, Scognmiglio A, Galetti P, Chiariello M, Zappia V.  
Oleuropein prevents oxidative myocardial injury by ischemia and reperfusion.  
J Nutr Biochem. 2004; 15: 461–468. 
doi:10.1016/j.jnutbio.2003.12.010 
[48]  De la Puerta R, Guttierrez VR, Hoult JRS.  
Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil.  
Biochem Pharmacol. 1999; 57: 445–449. 
doi:10.1016/S0006-2952(98)00320-7 
[49]  Visioli F, Caruso D, Galli C, Viappiani S, Galli G, Sala A.  
Olive oil rich in natural catecholic phenols decrease isoprostane excretion in humans.  
Biochem Biophys Res Commun. 2000; 278: 797–799. 
doi:10.1006/bbrc.2000.3879 
[50]  Visioli F, Galli C.  
Antiatherogenic components of olive oil.  
Curr Atheroscler Rep. 2001; 3: 64–67. 
doi:10.1007/s11883-001-0012-0 150  S. H. Omar:   
Sci Pharm. 2010; 78: 133–154. 
[51]  Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, Distante A, De 
Caterina R.  
Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties 
of Mediterranean diet phytochemicals.  
Arterioscler Thromb Vasc Biol. 2003;23(4):622–629. 
doi:10.1161/01.ATV.0000062884.69432.A0 
[52]  Hamdi HK, Castellon R. 
Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor.  
Biochem Biophys Res Commun. 2005; 334: 769–778. 
doi:10.1016/j.bbrc.2005.06.161 
[53]  Menendez JA, Vazquez-Martin A, Colomer R, Brunet J, Carrasco-Pancorbo A, Garcia-Villalba R, 
Fernandez-Gutierrez A, Segura-Carretero A.  
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-
overexpressing breast cancer cells.  
BMC Cancer. 2007; 7: 80. 
doi:10.1186/1471-2407-7-80 
[54]  Menendez JA, Vazquez-Martin A, Garcia-Villalba R, Carrasco-Pancorbo A, Oliveras-Ferraros C, 
Fernandez-Gutierrez A, Segura-Carretero A.  
tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial 
Extra-Virgin Olive Oil (EVOO).  
BMC Cancer. 2008; 8: 377. 
doi:10.1186/1471-2407-8-377 
[55]  Han J, Talorete TP, Yamada P, Isoda H.  
Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-
7 cells.  
Cytotechnology. 2009; 59: 45–53. 
doi:10.1007/s10616-009-9191-2 
[56]  Goulas V, Exarchou V, Troganis AN, Psomiadou E, Fotsis T, Briasoulis E, Gerothanassis IP.  
Phytochemicals in olive-leaf extracts and their antiproliferative activity against cancer and endothelial 
cells.  
Mol Nutr Food Res. 2009; 53: 600–608. 
doi:10.1002/mnfr.200800204 
[57]  Bisignano G, Tomaino A, Lo Cascio R, Crisafi G, Uccella N, Saija A.  
On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol.  
J Pharm Pharmacol. 1999; 51: 971–974. 
doi:10.1211/0022357991773258 
[58]  Aziz NH, Farag SF, Mousa LA, Abo-Zaid MA.  
Comparative antibacterial and antifungal effects of some phenolic compounds.  
Microbios. 1998; 93: 43–54. 
PMid:9670554 
[59]  Fleming HP, Walter WM Jr, Etchells L.  
Antimicrobial properties of oleuropein and products of its hydrolysis from green olives.  
Appl Microbiol. 1973; 26: 777–782. 
PMid:4762397 
[60]  Furneri PM, Marino A, Saija A, Ucella N, Bisignano G.  
In vitro antimycoplasmal activity of oleuropein.  
Int J Antimicrob Agents. 2002; 20: 293–296. 
doi:10.1016/S0924-8579(02)00181-4 
[61]  Caturla N, Perez Fons L, Estepa A, Micol V.  
Differential effects of oleuropein, a biophenol from Olea europaea, on anionic and zwiterionic 
phospholipid model membranes.  
Chem Phys Lipids. 2005; 137: 2–17. 
doi:10.1016/j.chemphyslip.2005.04.003   Oleuropein in Olive and its Pharmacological Effects  151 
Sci Pharm. 2010; 78: 133–154. 
[62]  Saija A, Uccella N.  
Olive biophenols: functional effects on human well-being.  
Trends Food Sci Technol. 2001; 11: 357–363. 
doi:10.1016/S0924-2244(00)00068-6 
[63]  Walter WM Jr, Flemming HP, Etchells JL.  
Preparation of antimicrobial compounds by hydrolysis of oleuropein from green olives.  
Appl Microbiol. 1973; 26: 773–776. 
PMid:4762396 
[64]  Tassou CC, Nychas GJE, Board RG.  
Effect of phenolic compounds and oleuropein on the germination of Bacillus cereus T spores.  
Biotech Appl Biochem. 1991; 13: 231–237. 
PMid:1904245 
[65]  Tranter HS, Tassou SC, Nychas GJ.  
The effect of the olive phenolic compound, oleuropein, on growth and enterotoxin B production by 
Staphylococcus aureus.  
J Appl Bacteriol. 1993; 74: 253–259. 
doi:10.1111/j.1365-2672.1993.tb03023.x 
[66]  Tassou CC, Nychas GJE.  
Inhibition of Staphylococcus aureus by olive phenolics in broth and in a model food system.  
J Food Prot. 1994; 57: 120–124. 
[67]  Tassou CC, Nychas GJE.  
Inhibition of Salmonella enteritidis by oleuropein in broth and in a model food system.  
Lett Appl Microbiol. 1995; 20: 120–124. 
doi:10.1111/j.1472-765X.1995.tb01301.x 
[68]  Sudjana AN, D'Orazio C, Ryan V, Rasool N, Ng J, Islam N, Riley TV, Hammer KA. 
Antimicrobial activity of commercial Olea europaea (olive) leaf extract.  
Int J Antimicrob Agents. 2009; 33: 461–463. 
doi:10.1016/j.ijantimicag.2008.10.026 
[69]  Fredrickson, WR, F and S Group, Inc. 
Method and Composition for Antiviral Therapy with Olive Leaves. 
U.S. Patent. 2000; 6: 117:884. 
[70]  Ma SC, He ZD, Deng XL, But PP, Ooi VE, Xu HX, Lee SH, Lee SF.  
In vitro evaluation of secoiridoid glucosides from the fruits of Ligustrum lucidum as antiviral agents.  
Chem Pharm Bull. 2001; 49: 1471–1473. 
doi:10.1248/cpb.49.1471 
[71]  Walker M.  
Olive leaf extract. The new oral treatment to counteract most types of pathological organisms.  
Explore: The Journal of Science and Healing. 1996; 7: 31. 
[72]  Micol V, Caturla N, Perenz-Fons L, Mas L, Perez L, Estepa A.  
The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus 
(VHSV).  
Antivir Res. 2005; 66: 129–136. 
doi:10.1016/j.antiviral.2005.02.005 
[73]  Lee-Huang S, Zhang L, Chang YY, Huang PL.  
Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 
infection and OLE treatment.  
Biochem Biophys Res Commun. 2003; 307: 1029–1037. 
doi:10.1016/S0006-291X(03)01292-0 152  S. H. Omar:   
Sci Pharm. 2010; 78: 133–154. 
[74]  Lee-Huang S, Huang PL, Zhang D, Lee JW, Bao J, Sun Y, Chang YT, Zhang J, Huang PL.  
Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and Hydroxytyrosol:  
Part I. Integrase Inhibition. 
Biochem Biophys Res Commun. 2007; 354: 872–878. 
doi:10.1016/j.bbrc.2007.01.071 
[75]  Ancora C, Roma C, Vettor M.  
Evaluation of cosmetic efficacy of oleoeuropein.  
Symposium on the New Frontiers of Dermo-cosmetology: Efficacy, Stability and Safety. Rome, Italy, 
November 4–6; 2004. 
[76]  Kimura Y, Sumiyoshi M.  
Olive leaf extract and its main component oleuropein prevent chronic ultraviolet B radiation-induced 
skin damage and carcinogenesis in hairless mice.  
J Nutr. 2009 ; 139: 2079–2086. 
doi:10.3945/jn.109.104992 
[77]  Katsiki M, Chondrogianni N, Chinou I, Rivett AJ, Gonos ES.  
The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life 
span extension of human embryonic fibroblasts.  
Rejuvenation Res. 2007; 10: 157–172. 
doi:10.1089/rej.2006.0513 
[78]  Moosmann B, Behl C.  
The Antioxidant Neuroprotective Effects of Estrogens and Phenolic Compounds are Independent from 
their Estrogenic Properties.  
Proc Natl Acad Sci USA. 1999; 96: 8867–8872. 
PMid:10430862 
[79]  German JB, Walzem RL.  
The Health Benefits of Wine.  
Annu Rev Nutr. 2000; 20: 561–593. 
doi:10.1146/annurev.nutr.20.1.561 
[80]  Bazoti FN, Bergquist J, Markides K, Tsarbopoulos A.  
Noncovalent Interaction between Amyloid-β-Peptide (1– 40) and Oleuropein Studied by Electrospray 
Ionization Mass Spectrometry.  
J Am Soc Mass Spectrom. 2006; 17: 568–575. 
doi:10.1016/j.jasms.2005.11.016 
[81]  Golde TE, Eckman CB.  
Cholesterol Modulation as an Emerging Strategy for the Treatment of Alzheimer’s Disease.  
Drug Discov Today. 2001; 6: 1049–1055. 
doi:10.1016/S1359-6446(01)01965-1 
[82]  Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, 
Van Broeckhoven C, Grobbee DE. 
Atherosclerosis, Apolipoprotein E, and Prevalence of Dementia and Alzheimer’s Disease in the 
Rotterdam Study.  
Lancet. 1997; 349: 151–154. 
doi:10.1016/S0140-6736(96)09328-2 
[83]  Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, 
Pappolla MA.  
Hypercholesterolemia Accelerates the Alzheimer’s Amyloid Pathology in a Transgenic Mouse Model.  
Neurobiol Dis. 2000; 7: 321–331. 
doi:10.1006/nbdi.2000.0304   Oleuropein in Olive and its Pharmacological Effects  153 
Sci Pharm. 2010; 78: 133–154. 
[84]  Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, Tint GS, Wang R, 
Mercken M, Petanceska SS, Duff KE.  
A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of 
Alzheimer’s Disease.  
Neurobiol Dis. 2001; 8: 890–899. 
doi:10.1006/nbdi.2001.0422 
[85]  Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA.  
Statins and the Risk of Dementia.  
Lancet. 2000; 356: 1627–1631. 
doi:10.1016/S0140-6736(00)03155-X 
[86]  Markesbery, WR, Carney JM.  
Oxidative Alterations in Alzheimer’s Disease.  
Brain Pathol. 1999; 9: 133–146. 
doi:10.1111/j.1750-3639.1999.tb00215.x 
[87]  Heininger K.  
A Unifying Hypothesis of Alzheimer’s Disease. II. Pathophysiological Processes.  
Hum Psychopharmacol Clin Exp. 1999; 14: 525–581. 
doi:10.1002/(SICI)1099-1077(199912)14:8<525::AID-HUP140>3.0.CO;2-T 
[88]  Stewart WF, Kawas C, Corrada M, Metter EJ.  
Risk of Alzheimer’s Disease and Duration of NSAID Use.  
Neurology. 1997; 48: 626–632. 
PMid:9065537 
[89]  Petkov V, Manolov P.  
Pharmacological studies on substances of plant origin with coronary dilatating and antiarrhythmatic 
action.  
Comp Med East West. 1978; 6: 123–130. 
PMid:750171 
[90]  Petroni A, Blasevich M, Salami M, Papini N, Montedoro GF, Galli C.  
Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil.  
Thromb Res 1995; 78: 151–160. 
doi:10.1016/0049-3848(95)00043-7 
[91]  Ribeiro Rde A, de Melo, MM Fiuza, De Barros F, Gomes C, Trolin G.  
Acute antihypertensive effect in conscious rats produced by some medicinal plants used in the state of 
Sao Paulo.  
J Ethnopharmacol. 1986; 15: 261–269. 
doi:10.1016/0378-8741(86)90164-9 
[92]  Khayyal MT, el-Ghazaly MA, Abdallah DM, Nassar NN, Okpanyi SN, Kreuter MH.  
Blood pressure lowering effect of an olive leaf extract (Olea europaea) in L-NAME induced 
hypertension in rats.  
Arzneimittelforschung. 2002; 52: 797–802. 
PMid:12489249 
[93]  Visioli F, Bellomo G, Montedoro GF, Galli C.  
Low-density lipoprotein oxidation is inhibited in vitro by olive oil constituents.  
Atherosclerosis. 1995; 117: 25–32. 
 doi:10.1016/0021-9150(95)05546-9 
[94]  Andrikopoulos NK, Kaliora AC, Assimopoulou AN, Papageorgiou VP.  
Inhibitory activity of minor polyphenolic and nonpolyphenolic constituents of olive oil against in vitro 
low-density lipoprotein oxidation.  
J Med Food. 2002; 5: 1–7. 
doi:10.1089/109662002753723160 154  S. H. Omar:   
Sci Pharm. 2010; 78: 133–154. 
[95]  Gonzalez M, Zarzuelo A, Gamez MJ, Utrilla MP, Jimenez J, Osuna I.  
Hypoglycemic activity of olive leaf.  
Planta Med. 1992; 58: 513–515. 
doi:10.1055/s-2006-961538 
[96]  Al-Azzawie HF, Alhamdani MS. 
Hypoglycemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits.  
Life Sci. 2006; 78: 1371–1377. 
doi:10.1016/j.lfs.2005.07.029 